THE BE T
Multimedia Highlights
From the CardioSource WorldNews YouTube Channel | Scan the QR code to watch the full video
Mapping the Way for Device
Placement in Adults with Congenital
Heart Disease
Huge Analysis Reveals Outcomes of
Surgical and Endovascular Procedures
for CLI
Ulrich P. Jorde, MD: “We have a lot more
patients with congenital heart disease who, in
the past, used to simply die—but, nowadays,
through great advances in diagnosis and
surgical maneuvering, still live long in a
time when there are more adult congenital
heart patients than children. These patients
will, unfortunately, develop congestive
heart failure, but here comes mechanical
circulatory support.”
Mehdi H. Shishehbor, DO, MPH, PhD:
“There’s been an uptake in these procedures
because, in general, folks feel these
procedures are low risk, they are minimally
invasive, and patients always like it when you
are offering them something less invasive,
relative to surgery.”
Farooqi KM, Saeed O, Zaidi A, et al.
JCHF. 2016;4:301-11.
Agarwal S, Sud K, Shishehbor M.
J Am Coll Cardiol. 2016;67(16):1901-1913
Margolies L, Salvatore M, Hecht HS,
et al. J Am Coll Cardiol Img.
2016;9(4):350-60.
One-year Results of TOTA: Prospective
Randomized Trial of Thrombus
Aspiration in Patients with STSegment Elevation MI
The Future of Cardiac Electrophysiology
Results of the Ix-Cell DCM Trial
Anne Curti s, MD: “There’s still plenty to be
done—a lot to learn about arrhythmias. We
will continue to be doing a lot with atrial
fibrillation and device therapies. None of that
is going to go away. We have a continuing
need with the population getting older and
the amount of heart disease we have. There
is a lot of need for people who are experts in
arrhythmia management.”
Timothy D. Henry, MD: “The primary
endpoint of the trial was to look at events.
It was a composite of death, cardiovascular
hospitalizations, and acute clinic visits for
decompensated heart failure. The trial looked
at high-risk patients with high clinical events.
So the good thing for us was that the primary
endpoint was positive.”
Sanjit S. Jolly, MD: “In TOTAL, we had
randomized to PCI alone who we ballooned
and, despite ballooning, you couldn’t get
the vessel open large enough. The heavy
thrombus burden reduced TIMI flow and you
can’t place your stent.”
Can Breast Cancer Screening Reveal
CVD Risk?
Jagat Narula, MD, PhD: “It is well known that
breast arterial calcification has some relationship
with coronary artery calcium, although we do know
that the mechanisms of the calcifications of breast
arteries vs. coronary artery is quite different. In the
breast artery, it is more of a medial calcification;
on the other hand, in the coronary artery, it is
more of a neointimal calcification. So although
the mechanisms are different, there has been a
relationship.”
Jolly SS, Cairns JA, Yusuf S, et al.
N Engl J Med. 2015; 372:1389-98.
14
CardioSource WorldNews
May 2016